Date: 2017-01-19
Type of information: Company acquisition
Acquired company: Martindale Pharma (UK)
Acquiring company: Ethypharm (France)
Amount:
Terms: * On January 19, 2017, Ethypharm announced that it has signed a definitive agreement to acquire Martindale Pharma. The combination of the two companies will create a group with revenues of more than €300 million and a solid platform for future growth. Michael Harris, CEO of Martindale Pharma will be the future Chief Operating Officer of Ethypharm.
Details: Martindale Pharma is a leading UK-based specialty pharmaceutical company providing essential medicines to over 50 countries around the world. The company specializes in the field of opioid addiction, emergency care and sterile injectables. By joining forces with Martindale Pharma, Ethypharm reinforces its presence in the UK. The combined group will also benefit from a broader geographical reach and strengthen its manufacturing capabilities including solid dose, injectables and oral liquids.
Related:
